IVERIC bio Inc. (ISEE)
NASDAQ: ISEE
· Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM
IVERIC bio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 467.57M | 476.3M | 153.1M | 141.11M | 191.87M | 261.45M | 179.88M | 50.36M | 29.34M |
Short-Term Investments | 132.35M | 170.53M | 167.44M | 170.85M | 153.8M | 120.3M | 62.09M | 109.52M | 150.87M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 1.87M | n/a | n/a | n/a | n/a | n/a | n/a | 2K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.76M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 11.62M | 15.99M | 8.94M | 5.26M | 5.3M | 5.74M | 4.07M | 3.81M | 5.31M |
Total Current Assets | 611.54M | 662.83M | 329.48M | 317.22M | 350.97M | 387.49M | 246.04M | 163.69M | 187.28M |
Property-Plant & Equipment | 1.86M | 2.13M | 2.31M | 2.53M | 1.74M | 1.87M | 1.75M | 1.98M | 124K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.86M | 4M | 2.31M | 2.53M | 1.74M | 1.87M | 1.75M | 1.98M | 126K |
Total Assets | 613.41M | 666.82M | 331.79M | 319.76M | 352.7M | 389.36M | 247.79M | 165.67M | 187.4M |
Account Payables | 18.03M | 22.84M | 11.6M | 8.18M | 5.29M | 12.86M | 8.13M | 8.64M | 6.98M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 774K | 1.19M | 1.6M | 1.72M | 955K | 952K | 945K | 937K | 55K |
Other Current Liabilities | 20.57M | 11.55M | 11.38M | 16.58M | 12.92M | 14.4M | 11.37M | 15.41M | 13.13M |
Total Current Liabilities | 39.37M | 35.59M | 24.59M | 26.48M | 19.17M | 28.21M | 20.44M | 24.99M | 20.16M |
Long-Term Debt | 96.99M | 96.58M | 47.68M | 331K | 385K | 619K | 861K | 1.1M | 51K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 96.99M | 96.58M | 47.68M | 331K | 385K | 619K | 861K | 1.1M | 51K |
Total Liabilities | 136.36M | 132.17M | 72.26M | 26.81M | 19.55M | 28.83M | 21.3M | 26.09M | 20.21M |
Total Debt | 97.76M | 97.77M | 49.28M | 2.06M | 1.34M | 1.57M | 1.81M | 2.04M | 106K |
Common Stock | 137K | 137K | 121K | 117K | 116K | 115K | 104K | 90K | 90K |
Retained Earnings | -937.03M | -864.81M | -805.75M | -763.39M | -714.13M | -679.6M | -646.56M | -622.01M | -591.87M |
Comprehensive Income | -99K | -229K | -395K | -528K | -394K | -90K | -11K | 3K | 2K |
Shareholders Equity | 477.05M | 534.75M | 259.8M | 292.95M | 333.15M | 360.53M | 226.49M | 139.57M | 167.19M |
Total Investments | 132.35M | 170.53M | 167.44M | 170.85M | 153.8M | 120.3M | 62.09M | 109.52M | 150.87M |